Michelle A. Wood-Trageser

Michelle A. Wood-Trageser

Auto-generated profile, based on publicly available information

Michelle A. Wood-Trageser

Department of Pathology University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SASaleh AlAsiri
Saleh AlAsiri
SBSulman Basit
Sulman Basit
MWMichelle A. Wood-Trageser
Michelle A. Wood-Trageser
SYSvetlana A. Yatsenko
Svetlana A. Yatsenko
EJElizabeth P. Jeffries
Elizabeth P. Jeffries
ARAleksandar Rajkovic
Aleksandar Rajkovic
Premature ovarian failure (POF) is a genetically and phenotypically heterogeneous disorder that includes individuals with manifestations ranging from primary amenorrhea to loss of menstrual function prior to age 40. POF presents as hypergonadotropic hypogonadism and can be part of a syndrome or occur in isolation. Here, we studied 3 sisters with primary amenorrhea, hypothyroidism, and hypergonadotropic hypogonadism. The sisters were born to parents who are first cousins. SNP analysis and whole-exome sequencing revealed the presence of a pathogenic variant of the minichromosome maintenance 8 gene (MCM8, c.446C>G; p.P149R) located within a region of homozygosity that was present in the affected daughters but not in their unaffected sisters. Because MCM8 participates in homologous recombination and dsDNA break repair, we tested fibroblasts from the affected sisters for hypersensitivity to chromosomal breaks. Compared with fibroblasts from unaffected daughters, chromosomal break repair was deficient in fibroblasts from the affected individuals, likely due to inhibited recruitment of MCM8 p.P149R to sites of DNA damage. Our study identifies an autosomal recessive disorder caused by an MCM8 mutation that manifests with endocrine dysfunction and genomic instability.

1 December 2014 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MWMichelle A. Wood-Trageser
Michelle A. Wood-Trageser
FGFatih Gürbüz
Fatih Gürbüz
SYSvetlana A. Yatsenko
Svetlana A. Yatsenko
EJElizabeth P. Jeffries
Elizabeth P. Jeffries
LKL. Damla Kotan
L. Damla Kotan
ARAleksandar Rajkovic
Aleksandar Rajkovic

1 September 2012 in The American Journal of Pathology
Verified
Journal Article
Open access
JHJoanne H. Heaton
Joanne H. Heaton
MWMichelle A. Wood
Michelle A. Wood
AKAlex C. Kim
Alex C. Kim
LLLorena O. Lima
Lorena O. Lima
FBFerdous M. Barlaskar
Ferdous M. Barlaskar
GHGary D. Hammer
Gary D. Hammer
Dysregulation of the WNT and insulin-like growth factor 2 (IGF2) signaling pathways has been implicated in sporadic and syndromic forms of adrenocortical carcinoma (ACC). Abnormal β-catenin staining and CTNNB1 mutations are reported to be common in both adrenocortical adenoma and ACC, whereas elevated IGF2 expression is associated primarily with ACC. To better understand the contribution of these pathways in the tumorigenesis of ACC, we examined clinicopathological and molecular data and used mouse models. Evaluation of adrenal tumors from 118 adult patients demonstrated an increase in CTNNB1 mutations and abnormal β-catenin accumulation in both adrenocortical adenoma and ACC. In ACC, these features were adversely associated with survival. Mice with stabilized β-catenin exhibited a temporal progression of increased adrenocortical hyperplasia, with subsequent microscopic and macroscopic adenoma formation. Elevated Igf2 expression alone did not cause hyperplasia. With the combination of stabilized β-catenin and elevated Igf2 expression, adrenal glands were larger, displayed earlier onset of hyperplasia, and developed more frequent macroscopic adenomas (as well as one carcinoma). Our results are consistent with a model in which dysregulation of one pathway may result in adrenal hyperplasia, but accumulation of a second or multiple alterations is necessary for tumorigenesis.

12 August 2020 in Hepatology
Verified
Journal Article
Closed access
PDF file
SFSandy Feng
Sandy Feng
JBJohn C. Bucuvalas
John C. Bucuvalas
GMGeorge V. Mazariegos
George V. Mazariegos
JMJohn C. Magee
John C. Magee
ASAlberto Sanchez‐Fueyo
Alberto Sanchez‐Fueyo
ADAnthony J. Demetris
Anthony J. Demetris

15 November 2013 in Development
Verified
Journal Article
Closed access
PDF file
MWMichelle A. Wood
Michelle A. Wood
AAAsha Acharya
Asha Acharya
IFIsabella Finco
Isabella Finco
JSJessica M. Swonger
Jessica M. Swonger
MEMarlee J. Elston
Marlee J. Elston
GHGary D. Hammer
Gary D. Hammer
The lineage relationships of fetal adrenal cells and adrenal capsular cells to the differentiated adrenal cortex are not fully understood. Existing data support a role for each cell type as a progenitor for cells of the adult cortex. This report reveals that subsets of capsular cells are descendants of fetal adrenocortical cells that once expressed Nr5a1. These fetal adrenocortical cell descendants within the adrenal capsule express Gli1, a known marker of progenitors of steroidogenic adrenal cells. The capsule is also populated by cells that express Tcf21, a known inhibitor of Nr5a1 gene expression. We demonstrate that Tcf21-expressing cells give rise to Nr5a1-expressing cells but only before capsular formation. After the capsule has formed, capsular Tcf21-expressing cells give rise only to non-steroidogenic stromal adrenocortical cells, which also express collagen 1a1, desmin and platelet-derived growth factor (alpha polypeptide) but not Nr5a1. These observations integrate prior observations that define two separate origins of adult adrenocortical steroidogenic cells (fetal adrenal cortex and/or the adrenal capsule). Thus, these observations predict a unique temporal and/or spatial role of adult cortical cells that arise directly from either fetal cortical cells or from fetal cortex-derived capsular cells. Last, the data uncover the mechanism by which two populations of fetal cells (fetal cortex derived Gli1-expressing cells and mesenchymal Tcf21-expressing mesenchymal cells) participate in the establishment of the homeostatic capsular progenitor cell niche of the adult cortex.

14 April 2023 in Science Immunology
Verified
Journal Article
Closed access
RTRoger Tieu
Roger Tieu
QZQiang Zeng
Qiang Zeng
DZDaqiang Zhao
Daqiang Zhao
GZGang Zhang
Gang Zhang
NFNeda Feizi
Neda Feizi
FLFadi G. Lakkis
Fadi G. Lakkis
Our understanding of tissue-resident memory T (T RM ) cell biology has been largely developed from acute infection models in which antigen is cleared and sterilizing immunity is achieved. Less is known about T RM cells in the context of chronic antigen persistence and inflammation. We investigated factors that underlie T RM maintenance in a kidney transplantation model in which T RM cells drive rejection. In contrast to acute infection, we found that T RM cells declined markedly in the absence of cognate antigen, antigen presentation, or antigen sensing by the T cells. Depletion of graft-infiltrating dendritic cells or interruption of antigen presentation after T RM cells were established was sufficient to disrupt T RM maintenance and reduce allograft pathology. Likewise, removal of IL-15 transpresentation or of the IL-15 receptor on T cells during T RM maintenance led to a decline in T RM cells, and IL-15 receptor blockade prevented chronic rejection. Therefore, antigen and IL-15 presented by dendritic cells play nonredundant key roles in CD8 T RM cell maintenance in settings of antigen persistence and inflammation. These findings provide insights that could lead to improved treatment of chronic transplant rejection and autoimmunity.